nodes	percent_of_prediction	percent_of_DWPC	metapath
Posaconazole—ABCB1—Lisinopril—systemic scleroderma	0.139	0.272	CbGbCtD
Posaconazole—ABCB1—Captopril—systemic scleroderma	0.104	0.203	CbGbCtD
Posaconazole—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.082	0.16	CbGbCtD
Posaconazole—ABCB1—Prednisone—systemic scleroderma	0.0655	0.128	CbGbCtD
Posaconazole—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0491	0.0959	CbGbCtD
Posaconazole—CYP3A4—Prednisone—systemic scleroderma	0.0393	0.0767	CbGbCtD
Posaconazole—ABCB1—Methotrexate—systemic scleroderma	0.0329	0.0642	CbGbCtD
Posaconazole—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000156	0.000319	CcSEcCtD
Posaconazole—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000155	0.000318	CcSEcCtD
Posaconazole—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000155	0.000317	CcSEcCtD
Posaconazole—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000155	0.000317	CcSEcCtD
Posaconazole—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000155	0.000317	CcSEcCtD
Posaconazole—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000155	0.000317	CcSEcCtD
Posaconazole—Myocardial infarction—Prednisone—systemic scleroderma	0.000155	0.000317	CcSEcCtD
Posaconazole—Breast disorder—Methotrexate—systemic scleroderma	0.000155	0.000317	CcSEcCtD
Posaconazole—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000154	0.000316	CcSEcCtD
Posaconazole—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000154	0.000316	CcSEcCtD
Posaconazole—Hypersensitivity—Azathioprine—systemic scleroderma	0.000154	0.000315	CcSEcCtD
Posaconazole—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000154	0.000315	CcSEcCtD
Posaconazole—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000154	0.000315	CcSEcCtD
Posaconazole—Insomnia—Lisinopril—systemic scleroderma	0.000153	0.000314	CcSEcCtD
Posaconazole—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000153	0.000314	CcSEcCtD
Posaconazole—Paraesthesia—Lisinopril—systemic scleroderma	0.000152	0.000312	CcSEcCtD
Posaconazole—Vomiting—Captopril—systemic scleroderma	0.000152	0.000312	CcSEcCtD
Posaconazole—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000151	0.00031	CcSEcCtD
Posaconazole—Dyspnoea—Lisinopril—systemic scleroderma	0.000151	0.00031	CcSEcCtD
Posaconazole—Rash—Captopril—systemic scleroderma	0.000151	0.000309	CcSEcCtD
Posaconazole—Dermatitis—Captopril—systemic scleroderma	0.000151	0.000309	CcSEcCtD
Posaconazole—Somnolence—Lisinopril—systemic scleroderma	0.000151	0.000309	CcSEcCtD
Posaconazole—Headache—Captopril—systemic scleroderma	0.00015	0.000307	CcSEcCtD
Posaconazole—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.00015	0.000307	CcSEcCtD
Posaconazole—Dyspepsia—Lisinopril—systemic scleroderma	0.000149	0.000306	CcSEcCtD
Posaconazole—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000149	0.000305	CcSEcCtD
Posaconazole—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000149	0.000305	CcSEcCtD
Posaconazole—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000148	0.000304	CcSEcCtD
Posaconazole—Infection—Mycophenolate mofetil—systemic scleroderma	0.000148	0.000302	CcSEcCtD
Posaconazole—Decreased appetite—Lisinopril—systemic scleroderma	0.000147	0.000302	CcSEcCtD
Posaconazole—Eosinophilia—Methotrexate—systemic scleroderma	0.000146	0.0003	CcSEcCtD
Posaconazole—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000146	0.0003	CcSEcCtD
Posaconazole—Fatigue—Lisinopril—systemic scleroderma	0.000146	0.000299	CcSEcCtD
Posaconazole—Shock—Mycophenolate mofetil—systemic scleroderma	0.000146	0.000299	CcSEcCtD
Posaconazole—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000146	0.000298	CcSEcCtD
Posaconazole—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000145	0.000298	CcSEcCtD
Posaconazole—Hypersensitivity—Leflunomide—systemic scleroderma	0.000145	0.000298	CcSEcCtD
Posaconazole—Pancreatitis—Methotrexate—systemic scleroderma	0.000145	0.000297	CcSEcCtD
Posaconazole—Constipation—Lisinopril—systemic scleroderma	0.000145	0.000297	CcSEcCtD
Posaconazole—Pain—Lisinopril—systemic scleroderma	0.000145	0.000297	CcSEcCtD
Posaconazole—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000145	0.000297	CcSEcCtD
Posaconazole—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000144	0.000296	CcSEcCtD
Posaconazole—Bradycardia—Prednisone—systemic scleroderma	0.000144	0.000296	CcSEcCtD
Posaconazole—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000144	0.000294	CcSEcCtD
Posaconazole—Diarrhoea—Azathioprine—systemic scleroderma	0.000143	0.000293	CcSEcCtD
Posaconazole—Haemoglobin—Prednisone—systemic scleroderma	0.000142	0.000292	CcSEcCtD
Posaconazole—Nausea—Captopril—systemic scleroderma	0.000142	0.000291	CcSEcCtD
Posaconazole—Haemorrhage—Prednisone—systemic scleroderma	0.000142	0.00029	CcSEcCtD
Posaconazole—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000142	0.00029	CcSEcCtD
Posaconazole—Asthenia—Leflunomide—systemic scleroderma	0.000142	0.00029	CcSEcCtD
Posaconazole—Pancytopenia—Methotrexate—systemic scleroderma	0.00014	0.000288	CcSEcCtD
Posaconazole—Feeling abnormal—Lisinopril—systemic scleroderma	0.00014	0.000286	CcSEcCtD
Posaconazole—Pruritus—Leflunomide—systemic scleroderma	0.00014	0.000286	CcSEcCtD
Posaconazole—Connective tissue disorder—Prednisone—systemic scleroderma	0.000139	0.000285	CcSEcCtD
Posaconazole—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000139	0.000284	CcSEcCtD
Posaconazole—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000139	0.000284	CcSEcCtD
Posaconazole—Neutropenia—Methotrexate—systemic scleroderma	0.000138	0.000283	CcSEcCtD
Posaconazole—Dysuria—Methotrexate—systemic scleroderma	0.000138	0.000283	CcSEcCtD
Posaconazole—Dizziness—Azathioprine—systemic scleroderma	0.000138	0.000283	CcSEcCtD
Posaconazole—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000137	0.000282	CcSEcCtD
Posaconazole—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000135	0.000277	CcSEcCtD
Posaconazole—Asthenia—Mycophenolic acid—systemic scleroderma	0.000135	0.000277	CcSEcCtD
Posaconazole—Diarrhoea—Leflunomide—systemic scleroderma	0.000135	0.000277	CcSEcCtD
Posaconazole—Urticaria—Lisinopril—systemic scleroderma	0.000135	0.000276	CcSEcCtD
Posaconazole—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000134	0.000275	CcSEcCtD
Posaconazole—Body temperature increased—Lisinopril—systemic scleroderma	0.000134	0.000275	CcSEcCtD
Posaconazole—Abdominal pain—Lisinopril—systemic scleroderma	0.000134	0.000275	CcSEcCtD
Posaconazole—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000133	0.000273	CcSEcCtD
Posaconazole—Pruritus—Mycophenolic acid—systemic scleroderma	0.000133	0.000273	CcSEcCtD
Posaconazole—Vomiting—Azathioprine—systemic scleroderma	0.000133	0.000272	CcSEcCtD
Posaconazole—Pneumonia—Methotrexate—systemic scleroderma	0.000133	0.000272	CcSEcCtD
Posaconazole—Eye disorder—Prednisone—systemic scleroderma	0.000132	0.000271	CcSEcCtD
Posaconazole—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000132	0.000271	CcSEcCtD
Posaconazole—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000132	0.00027	CcSEcCtD
Posaconazole—Infestation NOS—Methotrexate—systemic scleroderma	0.000132	0.00027	CcSEcCtD
Posaconazole—Infestation—Methotrexate—systemic scleroderma	0.000132	0.00027	CcSEcCtD
Posaconazole—Rash—Azathioprine—systemic scleroderma	0.000132	0.00027	CcSEcCtD
Posaconazole—Dermatitis—Azathioprine—systemic scleroderma	0.000132	0.00027	CcSEcCtD
Posaconazole—Flushing—Prednisone—systemic scleroderma	0.000131	0.000269	CcSEcCtD
Posaconazole—Headache—Azathioprine—systemic scleroderma	0.000131	0.000268	CcSEcCtD
Posaconazole—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000131	0.000268	CcSEcCtD
Posaconazole—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000131	0.000268	CcSEcCtD
Posaconazole—Dizziness—Leflunomide—systemic scleroderma	0.00013	0.000267	CcSEcCtD
Posaconazole—Renal failure—Methotrexate—systemic scleroderma	0.00013	0.000266	CcSEcCtD
Posaconazole—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000129	0.000264	CcSEcCtD
Posaconazole—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000129	0.000264	CcSEcCtD
Posaconazole—Stomatitis—Methotrexate—systemic scleroderma	0.000129	0.000263	CcSEcCtD
Posaconazole—Angiopathy—Prednisone—systemic scleroderma	0.000129	0.000263	CcSEcCtD
Posaconazole—Conjunctivitis—Methotrexate—systemic scleroderma	0.000128	0.000263	CcSEcCtD
Posaconazole—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000128	0.000263	CcSEcCtD
Posaconazole—Immune system disorder—Prednisone—systemic scleroderma	0.000128	0.000262	CcSEcCtD
Posaconazole—Pain—Mycophenolate mofetil—systemic scleroderma	0.000127	0.00026	CcSEcCtD
Posaconazole—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000127	0.00026	CcSEcCtD
Posaconazole—Arrhythmia—Prednisone—systemic scleroderma	0.000127	0.000259	CcSEcCtD
Posaconazole—Haematuria—Methotrexate—systemic scleroderma	0.000126	0.000258	CcSEcCtD
Posaconazole—Vomiting—Leflunomide—systemic scleroderma	0.000125	0.000257	CcSEcCtD
Posaconazole—Alopecia—Prednisone—systemic scleroderma	0.000125	0.000257	CcSEcCtD
Posaconazole—Hypersensitivity—Lisinopril—systemic scleroderma	0.000125	0.000256	CcSEcCtD
Posaconazole—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000125	0.000256	CcSEcCtD
Posaconazole—Dizziness—Mycophenolic acid—systemic scleroderma	0.000124	0.000255	CcSEcCtD
Posaconazole—Epistaxis—Methotrexate—systemic scleroderma	0.000124	0.000255	CcSEcCtD
Posaconazole—Rash—Leflunomide—systemic scleroderma	0.000124	0.000255	CcSEcCtD
Posaconazole—Dermatitis—Leflunomide—systemic scleroderma	0.000124	0.000255	CcSEcCtD
Posaconazole—Mental disorder—Prednisone—systemic scleroderma	0.000124	0.000254	CcSEcCtD
Posaconazole—Nausea—Azathioprine—systemic scleroderma	0.000124	0.000254	CcSEcCtD
Posaconazole—Headache—Leflunomide—systemic scleroderma	0.000124	0.000253	CcSEcCtD
Posaconazole—Erythema—Prednisone—systemic scleroderma	0.000123	0.000253	CcSEcCtD
Posaconazole—Malnutrition—Prednisone—systemic scleroderma	0.000123	0.000253	CcSEcCtD
Posaconazole—Agranulocytosis—Methotrexate—systemic scleroderma	0.000123	0.000252	CcSEcCtD
Posaconazole—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000122	0.000251	CcSEcCtD
Posaconazole—Asthenia—Lisinopril—systemic scleroderma	0.000122	0.000249	CcSEcCtD
Posaconazole—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000121	0.000249	CcSEcCtD
Posaconazole—Pruritus—Lisinopril—systemic scleroderma	0.00012	0.000246	CcSEcCtD
Posaconazole—Vomiting—Mycophenolic acid—systemic scleroderma	0.00012	0.000245	CcSEcCtD
Posaconazole—Haemoglobin—Methotrexate—systemic scleroderma	0.000119	0.000244	CcSEcCtD
Posaconazole—Rash—Mycophenolic acid—systemic scleroderma	0.000119	0.000243	CcSEcCtD
Posaconazole—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000119	0.000243	CcSEcCtD
Posaconazole—Hepatitis—Methotrexate—systemic scleroderma	0.000118	0.000243	CcSEcCtD
Posaconazole—Haemorrhage—Methotrexate—systemic scleroderma	0.000118	0.000243	CcSEcCtD
Posaconazole—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000118	0.000242	CcSEcCtD
Posaconazole—Headache—Mycophenolic acid—systemic scleroderma	0.000118	0.000242	CcSEcCtD
Posaconazole—Pharyngitis—Methotrexate—systemic scleroderma	0.000118	0.000241	CcSEcCtD
Posaconazole—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000117	0.000241	CcSEcCtD
Posaconazole—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000117	0.000241	CcSEcCtD
Posaconazole—Nausea—Leflunomide—systemic scleroderma	0.000117	0.00024	CcSEcCtD
Posaconazole—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000117	0.00024	CcSEcCtD
Posaconazole—Vision blurred—Prednisone—systemic scleroderma	0.000116	0.000238	CcSEcCtD
Posaconazole—Urethral disorder—Methotrexate—systemic scleroderma	0.000116	0.000238	CcSEcCtD
Posaconazole—Diarrhoea—Lisinopril—systemic scleroderma	0.000116	0.000238	CcSEcCtD
Posaconazole—Ill-defined disorder—Prednisone—systemic scleroderma	0.000114	0.000234	CcSEcCtD
Posaconazole—Anaemia—Prednisone—systemic scleroderma	0.000114	0.000234	CcSEcCtD
Posaconazole—Agitation—Prednisone—systemic scleroderma	0.000113	0.000232	CcSEcCtD
Posaconazole—Dizziness—Lisinopril—systemic scleroderma	0.000112	0.00023	CcSEcCtD
Posaconazole—Erythema multiforme—Methotrexate—systemic scleroderma	0.000112	0.000229	CcSEcCtD
Posaconazole—Nausea—Mycophenolic acid—systemic scleroderma	0.000112	0.000229	CcSEcCtD
Posaconazole—Malaise—Prednisone—systemic scleroderma	0.000111	0.000228	CcSEcCtD
Posaconazole—Vertigo—Prednisone—systemic scleroderma	0.000111	0.000227	CcSEcCtD
Posaconazole—Eye disorder—Methotrexate—systemic scleroderma	0.000111	0.000227	CcSEcCtD
Posaconazole—Syncope—Prednisone—systemic scleroderma	0.000111	0.000227	CcSEcCtD
Posaconazole—Tinnitus—Methotrexate—systemic scleroderma	0.00011	0.000226	CcSEcCtD
Posaconazole—Cardiac disorder—Methotrexate—systemic scleroderma	0.00011	0.000225	CcSEcCtD
Posaconazole—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000109	0.000224	CcSEcCtD
Posaconazole—Loss of consciousness—Prednisone—systemic scleroderma	0.000108	0.000222	CcSEcCtD
Posaconazole—Vomiting—Lisinopril—systemic scleroderma	0.000108	0.000221	CcSEcCtD
Posaconazole—Angiopathy—Methotrexate—systemic scleroderma	0.000107	0.00022	CcSEcCtD
Posaconazole—Immune system disorder—Methotrexate—systemic scleroderma	0.000107	0.000219	CcSEcCtD
Posaconazole—Rash—Lisinopril—systemic scleroderma	0.000107	0.000219	CcSEcCtD
Posaconazole—Convulsion—Prednisone—systemic scleroderma	0.000107	0.000219	CcSEcCtD
Posaconazole—Dermatitis—Lisinopril—systemic scleroderma	0.000107	0.000219	CcSEcCtD
Posaconazole—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000107	0.000219	CcSEcCtD
Posaconazole—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000107	0.000218	CcSEcCtD
Posaconazole—Hypertension—Prednisone—systemic scleroderma	0.000106	0.000218	CcSEcCtD
Posaconazole—Chills—Methotrexate—systemic scleroderma	0.000106	0.000218	CcSEcCtD
Posaconazole—Headache—Lisinopril—systemic scleroderma	0.000106	0.000218	CcSEcCtD
Posaconazole—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000105	0.000215	CcSEcCtD
Posaconazole—Myalgia—Prednisone—systemic scleroderma	0.000105	0.000215	CcSEcCtD
Posaconazole—Arthralgia—Prednisone—systemic scleroderma	0.000105	0.000215	CcSEcCtD
Posaconazole—Anxiety—Prednisone—systemic scleroderma	0.000105	0.000214	CcSEcCtD
Posaconazole—Alopecia—Methotrexate—systemic scleroderma	0.000105	0.000214	CcSEcCtD
Posaconazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000104	0.000214	CcSEcCtD
Posaconazole—Discomfort—Prednisone—systemic scleroderma	0.000104	0.000213	CcSEcCtD
Posaconazole—Mental disorder—Methotrexate—systemic scleroderma	0.000104	0.000213	CcSEcCtD
Posaconazole—Erythema—Methotrexate—systemic scleroderma	0.000103	0.000211	CcSEcCtD
Posaconazole—Malnutrition—Methotrexate—systemic scleroderma	0.000103	0.000211	CcSEcCtD
Posaconazole—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000102	0.000208	CcSEcCtD
Posaconazole—Dysgeusia—Methotrexate—systemic scleroderma	0.000101	0.000207	CcSEcCtD
Posaconazole—Nausea—Lisinopril—systemic scleroderma	0.000101	0.000206	CcSEcCtD
Posaconazole—Oedema—Prednisone—systemic scleroderma	0.000101	0.000206	CcSEcCtD
Posaconazole—Infection—Prednisone—systemic scleroderma	0.0001	0.000205	CcSEcCtD
Posaconazole—Back pain—Methotrexate—systemic scleroderma	9.97e-05	0.000204	CcSEcCtD
Posaconazole—Shock—Prednisone—systemic scleroderma	9.9e-05	0.000203	CcSEcCtD
Posaconazole—Nervous system disorder—Prednisone—systemic scleroderma	9.87e-05	0.000202	CcSEcCtD
Posaconazole—Tachycardia—Prednisone—systemic scleroderma	9.82e-05	0.000201	CcSEcCtD
Posaconazole—Dizziness—Mycophenolate mofetil—systemic scleroderma	9.82e-05	0.000201	CcSEcCtD
Posaconazole—Skin disorder—Prednisone—systemic scleroderma	9.78e-05	0.0002	CcSEcCtD
Posaconazole—Hyperhidrosis—Prednisone—systemic scleroderma	9.73e-05	0.000199	CcSEcCtD
Posaconazole—Vision blurred—Methotrexate—systemic scleroderma	9.71e-05	0.000199	CcSEcCtD
Posaconazole—Anorexia—Prednisone—systemic scleroderma	9.59e-05	0.000197	CcSEcCtD
Posaconazole—Ill-defined disorder—Methotrexate—systemic scleroderma	9.56e-05	0.000196	CcSEcCtD
Posaconazole—Anaemia—Methotrexate—systemic scleroderma	9.53e-05	0.000195	CcSEcCtD
Posaconazole—Vomiting—Mycophenolate mofetil—systemic scleroderma	9.44e-05	0.000193	CcSEcCtD
Posaconazole—Rash—Mycophenolate mofetil—systemic scleroderma	9.36e-05	0.000192	CcSEcCtD
Posaconazole—Dermatitis—Mycophenolate mofetil—systemic scleroderma	9.35e-05	0.000192	CcSEcCtD
Posaconazole—Headache—Mycophenolate mofetil—systemic scleroderma	9.3e-05	0.000191	CcSEcCtD
Posaconazole—Malaise—Methotrexate—systemic scleroderma	9.29e-05	0.00019	CcSEcCtD
Posaconazole—Vertigo—Methotrexate—systemic scleroderma	9.26e-05	0.00019	CcSEcCtD
Posaconazole—Leukopenia—Methotrexate—systemic scleroderma	9.23e-05	0.000189	CcSEcCtD
Posaconazole—Musculoskeletal discomfort—Prednisone—systemic scleroderma	9.17e-05	0.000188	CcSEcCtD
Posaconazole—Insomnia—Prednisone—systemic scleroderma	9.1e-05	0.000187	CcSEcCtD
Posaconazole—Paraesthesia—Prednisone—systemic scleroderma	9.04e-05	0.000185	CcSEcCtD
Posaconazole—Cough—Methotrexate—systemic scleroderma	8.99e-05	0.000184	CcSEcCtD
Posaconazole—Convulsion—Methotrexate—systemic scleroderma	8.93e-05	0.000183	CcSEcCtD
Posaconazole—Dyspepsia—Prednisone—systemic scleroderma	8.86e-05	0.000182	CcSEcCtD
Posaconazole—Nausea—Mycophenolate mofetil—systemic scleroderma	8.82e-05	0.000181	CcSEcCtD
Posaconazole—Myalgia—Methotrexate—systemic scleroderma	8.77e-05	0.00018	CcSEcCtD
Posaconazole—Arthralgia—Methotrexate—systemic scleroderma	8.77e-05	0.00018	CcSEcCtD
Posaconazole—Chest pain—Methotrexate—systemic scleroderma	8.77e-05	0.00018	CcSEcCtD
Posaconazole—Decreased appetite—Prednisone—systemic scleroderma	8.75e-05	0.000179	CcSEcCtD
Posaconazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	8.71e-05	0.000179	CcSEcCtD
Posaconazole—Fatigue—Prednisone—systemic scleroderma	8.68e-05	0.000178	CcSEcCtD
Posaconazole—Discomfort—Methotrexate—systemic scleroderma	8.67e-05	0.000178	CcSEcCtD
Posaconazole—Constipation—Prednisone—systemic scleroderma	8.61e-05	0.000176	CcSEcCtD
Posaconazole—Confusional state—Methotrexate—systemic scleroderma	8.48e-05	0.000174	CcSEcCtD
Posaconazole—Infection—Methotrexate—systemic scleroderma	8.36e-05	0.000171	CcSEcCtD
Posaconazole—Feeling abnormal—Prednisone—systemic scleroderma	8.29e-05	0.00017	CcSEcCtD
Posaconazole—Nervous system disorder—Methotrexate—systemic scleroderma	8.25e-05	0.000169	CcSEcCtD
Posaconazole—Thrombocytopenia—Methotrexate—systemic scleroderma	8.24e-05	0.000169	CcSEcCtD
Posaconazole—Gastrointestinal pain—Prednisone—systemic scleroderma	8.23e-05	0.000169	CcSEcCtD
Posaconazole—Skin disorder—Methotrexate—systemic scleroderma	8.17e-05	0.000167	CcSEcCtD
Posaconazole—Hyperhidrosis—Methotrexate—systemic scleroderma	8.13e-05	0.000167	CcSEcCtD
Posaconazole—Anorexia—Methotrexate—systemic scleroderma	8.02e-05	0.000164	CcSEcCtD
Posaconazole—Urticaria—Prednisone—systemic scleroderma	8e-05	0.000164	CcSEcCtD
Posaconazole—Body temperature increased—Prednisone—systemic scleroderma	7.96e-05	0.000163	CcSEcCtD
Posaconazole—Abdominal pain—Prednisone—systemic scleroderma	7.96e-05	0.000163	CcSEcCtD
Posaconazole—Hypotension—Methotrexate—systemic scleroderma	7.86e-05	0.000161	CcSEcCtD
Posaconazole—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	7.66e-05	0.000157	CcSEcCtD
Posaconazole—Insomnia—Methotrexate—systemic scleroderma	7.61e-05	0.000156	CcSEcCtD
Posaconazole—Paraesthesia—Methotrexate—systemic scleroderma	7.55e-05	0.000155	CcSEcCtD
Posaconazole—Dyspnoea—Methotrexate—systemic scleroderma	7.5e-05	0.000154	CcSEcCtD
Posaconazole—Somnolence—Methotrexate—systemic scleroderma	7.48e-05	0.000153	CcSEcCtD
Posaconazole—Hypersensitivity—Prednisone—systemic scleroderma	7.42e-05	0.000152	CcSEcCtD
Posaconazole—Dyspepsia—Methotrexate—systemic scleroderma	7.4e-05	0.000152	CcSEcCtD
Posaconazole—Decreased appetite—Methotrexate—systemic scleroderma	7.31e-05	0.00015	CcSEcCtD
Posaconazole—Gastrointestinal disorder—Methotrexate—systemic scleroderma	7.26e-05	0.000149	CcSEcCtD
Posaconazole—Fatigue—Methotrexate—systemic scleroderma	7.25e-05	0.000149	CcSEcCtD
Posaconazole—Asthenia—Prednisone—systemic scleroderma	7.22e-05	0.000148	CcSEcCtD
Posaconazole—Pain—Methotrexate—systemic scleroderma	7.19e-05	0.000147	CcSEcCtD
Posaconazole—Pruritus—Prednisone—systemic scleroderma	7.12e-05	0.000146	CcSEcCtD
Posaconazole—Feeling abnormal—Methotrexate—systemic scleroderma	6.93e-05	0.000142	CcSEcCtD
Posaconazole—Diarrhoea—Prednisone—systemic scleroderma	6.89e-05	0.000141	CcSEcCtD
Posaconazole—Gastrointestinal pain—Methotrexate—systemic scleroderma	6.88e-05	0.000141	CcSEcCtD
Posaconazole—Urticaria—Methotrexate—systemic scleroderma	6.68e-05	0.000137	CcSEcCtD
Posaconazole—Dizziness—Prednisone—systemic scleroderma	6.66e-05	0.000136	CcSEcCtD
Posaconazole—Abdominal pain—Methotrexate—systemic scleroderma	6.65e-05	0.000136	CcSEcCtD
Posaconazole—Body temperature increased—Methotrexate—systemic scleroderma	6.65e-05	0.000136	CcSEcCtD
Posaconazole—Vomiting—Prednisone—systemic scleroderma	6.4e-05	0.000131	CcSEcCtD
Posaconazole—Rash—Prednisone—systemic scleroderma	6.35e-05	0.00013	CcSEcCtD
Posaconazole—Dermatitis—Prednisone—systemic scleroderma	6.34e-05	0.00013	CcSEcCtD
Posaconazole—Headache—Prednisone—systemic scleroderma	6.31e-05	0.000129	CcSEcCtD
Posaconazole—Hypersensitivity—Methotrexate—systemic scleroderma	6.2e-05	0.000127	CcSEcCtD
Posaconazole—Asthenia—Methotrexate—systemic scleroderma	6.04e-05	0.000124	CcSEcCtD
Posaconazole—Nausea—Prednisone—systemic scleroderma	5.98e-05	0.000123	CcSEcCtD
Posaconazole—Pruritus—Methotrexate—systemic scleroderma	5.95e-05	0.000122	CcSEcCtD
Posaconazole—Diarrhoea—Methotrexate—systemic scleroderma	5.76e-05	0.000118	CcSEcCtD
Posaconazole—Dizziness—Methotrexate—systemic scleroderma	5.56e-05	0.000114	CcSEcCtD
Posaconazole—Vomiting—Methotrexate—systemic scleroderma	5.35e-05	0.00011	CcSEcCtD
Posaconazole—Rash—Methotrexate—systemic scleroderma	5.3e-05	0.000109	CcSEcCtD
Posaconazole—Dermatitis—Methotrexate—systemic scleroderma	5.3e-05	0.000109	CcSEcCtD
Posaconazole—Headache—Methotrexate—systemic scleroderma	5.27e-05	0.000108	CcSEcCtD
Posaconazole—Nausea—Methotrexate—systemic scleroderma	5e-05	0.000102	CcSEcCtD
